ArticleThoracic cancer2026

Transcriptomic Determinants of Circulating Immunity Predict Immune-Related Adverse Events (irAEs) in Cancer Patients Receiving PD-1/PD-L1 Blockade.

Liting You et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.